Management of hemopoietic neoplasias during pregnancy.
Hemopoietic neoplasias are unique cancers generally affecting bone marrow, and requires a special attention for disease control and also their complications. When these neoplastic disorders accompany to pregnancy there are many risks both for mother and foetus. Diagnostic difficulties due to the limited use of imaging modalities is essential in pregnant women. On the other hand suboptimal using of the anti-neoplastic drugs and their higher toxicity in mother and foetus must be considered in the management of these neoplastic disorders. Due to the lack of therapeutic guidelines in these cases, team approach is essential and therapy requires to the use the art of medicine.
Cukurova University Faculty of Medicine Dept. of Oncology, Adana, Turkey. Electronic address: sepay@cu.edu.tr.
Semra
S
Paydas
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D005333:Fetus; D019337:Hematologic Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009367:Neoplasm Staging; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*
D000970:Antineoplastic Agents
Chemotherapy; Fertility preservation; Hemopoietic neoplasia; Leukemia; Lymphoma; Myeloproliferative neoplasia; Pregnancy; Radiation therapy; Supportive care